Carvana (CVNA) Delivers First Quarterly Profit to Smash Estimates, Shares Surge as Firms Hike PTs Following a 'Milestone Quarter'

Carvana (CVNA) PT Raised to $400 at Needham & Company

Needham & Company analyst Chris Pierce raised the price target on Carvana (NYSE: CVNA) to $400.00 (from $325.00) while maintaining a Buy rating.

The analyst commented, "Another installment of this franchise delivers. CVNA beat handily on 2Q revenues and EBITDA, while reporting their first... More

Carvana (CVNA) PT Raised to $405 at Wells Fargo

Wells Fargo analyst Zachary Fadem raised the price target on Carvana (NYSE: CVNA) to $405.00 (from $385.00) while maintaining a Overweight rating.... More

Carvana (CVNA) PT Raised to $420 at BofA Securities

BofA Securities analyst Nat Schindler raised the price target on Carvana (NYSE: CVNA) to $420.00 (from $375.00) while maintaining a Buy rating.

Carvana (CVNA) PT Raised to $410 at KeyBanc

KeyBanc analyst Edward Yruma raised the price target on Carvana (NYSE: CVNA) to $410.00 (from $360.00) while maintaining a Overweight rating.... More

After-Hours Stock Movers 08/05: (GRPN) (CSOD) (CVNA) Higher; (DRNA) (ZNGA) (NVAX) Lower (more...)

After-Hours Movers

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) 25.5% LOWER; announced positive top-line results from the Companys PHYOX2 pivotal clinical trial of nedosiran, which is in development as a once-monthly treatment for primary hyperoxaluria (PH), a family of ultra-rare, life-threatening genetic disorders that initially manifest with complications in the kidneys. Nedosiran is Dicernas lead GalXC RNAi therapeutic candidate and is designed to inhibit the hepatic lactate dehydrogenase (LDH) enzyme an enzyme that catalyzes the final step in the glyoxylate metabolism pathway that can lead to oxalate overproduction in patients with PH. The... More

Carvana Co. (CVNA) Tops Q2 EPS by 67c, Sales Easily Beat

Carvana Co. (NYSE: CVNA) reported Q2 EPS of $0.26, $0.67 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.34 billion versus the consensus estimate of $2.44 billion.

This was a landmark quarter for Carvana. We delivered over 100,000 cars in the... More